Location History:
- Penfield, NY (US) (2020 - 2022)
- Bluffton, SC (US) (2023 - 2024)
Company Filing History:
Years Active: 2020-2024
Title: **Ivan M Nuñez: Visionary Inventor in Biomedical Devices**
Introduction
Ivan M Nuñez is a notable inventor based in Penfield, NY, with a remarkable portfolio of eight patents. His contributions to the field of biomedical engineering, particularly with water extractable ophthalmic devices and innovative biomedical devices, have significantly advanced healthcare technologies.
Latest Patents
Among Ivan's latest inventions is a pioneering water extractable ophthalmic device. This device is composed of a polymerization product derived from a specific monomeric mixture, which includes cyclic lactams, non-bulky organosilicon-containing monomers, bulky siloxane monomers, and a unique blend of crosslinking agents. The resulting device demonstrates an impressive equilibrium water content of approximately 50 wt. %, a contact angle of less than 50°, and an oxygen permeability exceeding 60 Barrers.
Another standout invention by Ivan is his innovative biomedical device. This device is formulated from a mixture that includes difunctional isocyanates, polyalcohols, hydroxy-terminated polysiloxane prepolymers, and polyoxazoline polyols with a significant weight average molecular weight of over 1000 Daltons. His work in this area reflects a deep commitment to enhancing medical solutions through advanced materials.
Career Highlights
Ivan has contributed to well-respected organizations, notably Bausch & Lomb Incorporated and Bausch + Lomb Ireland Limited. His tenure in these companies has enabled him to push the boundaries of innovation in ophthalmic and biomedical devices.
Collaborations
Throughout his career, Ivan has collaborated with notable colleagues, including Lynn Coullard and Analuz Mark. These partnerships have fostered a collaborative environment that thrives on the exchange of ideas and expertise in the biomedical field.
Conclusion
Ivan M Nuñez's innovative spirit and dedication to advancing biomedical technology are evidenced by his substantial patent portfolio and contributions to his field. His work continues to pave the way for new developments in ophthalmic and biomedical devices, reflecting a commitment to improving patient outcomes through innovation.